LLY announcements Eli Lilly And Company announcements and dividends declared NYSE
Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY
Eli Lilly And Company LLY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Eli Lilly And Company LLY
Pharma major Eli Lilly claims its weight loss drug reduces cardiovascular risks in Type 2 diabetes patients
Eli Lilly's Mounjaro demonstrates significant cardiovascular benefits for Type 2 diabetes patients with heart disease, reducing mortality and cardiovascular risks. The SURPASS-CVOT trial revealed Mounjaro's superiority over Trulicity, showing improvements
Announcement as on 31 July 2025
Eli Lilly to roll out diabetes medicine in prefilled pen
Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The KwikPen offers a convenient, once-weekly administration. It contains four fixed doses. This launch intensifies competition with No
Announcement as on 27 June 2025
Eli Lilly to launch Mounjaro KwikPen for type 2 diabetes in India
Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following regulatory approval. This offers a convenient option for adults with type 2 diabetes. Mounjaro, a dual GIP and GLP-1 receptor agon
Announcement as on 26 June 2025
Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand
Eli Lilly's Mounjaro has seen a positive reception in India, capturing significant sales and market interest since its launch in March. The company is prioritizing meeting the growing demand for the diabetes and weight-loss drug in the country, where obesi
Announcement as on 20 June 2025
Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
[content-module:CompanyOverview|NYSE:LLY] The world’s largest pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), recently had its worst day in a long, long time. On May 1, Lilly reported Q1 earnings. Afterwards, shares got beaten down by almost
Announcement as on 06 May 2025
Announcements by Eli Lilly And Company first page | Next page | Prev page |
LLY Eli Lilly And Company current price & indicator signals
Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 27 Fri Mar 2026 | 877.66 | 877.11 to 901.15 | -2.11% | 0.67 times |
| 26 Thu Mar 2026 | 896.61 | 896.29 to 917.96 | -2.15% | 0.48 times |
| 25 Wed Mar 2026 | 916.31 | 909.09 to 922.15 | 1.47% | 1 times |
| 24 Tue Mar 2026 | 903.02 | 895.61 to 908.67 | -0.83% | 1.18 times |
| 23 Mon Mar 2026 | 910.55 | 907.23 to 926.78 | 0.43% | 1.3 times |
| 20 Fri Mar 2026 | 906.63 | 899.29 to 925.38 | -1.19% | 0.88 times |
| 19 Thu Mar 2026 | 917.57 | 907.75 to 924.53 | -1.39% | 0.54 times |
| 17 Tue Mar 2026 | 930.50 | 925.25 to 985.00 | -5.93% | 1.56 times |
| 16 Mon Mar 2026 | 989.12 | 975.51 to 998.17 | 0.41% | 1.06 times |
| 13 Fri Mar 2026 | 985.08 | 978.00 to 1003.22 | 0.8% | 0.91 times |
| 12 Thu Mar 2026 | 977.25 | 973.16 to 994.50 | -2.2% | 1.08 times |
| 11 Wed Mar 2026 | 999.27 | 990.30 to 1003.38 | -0.21% | 0.3 times |
Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared NYSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


